𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pegylated interferon alfa 2B (PEG-IFN) and ribavirin for hepatitis C patients who were previous nonresponders to standard combination therapy: 24 week viral clearance: Eric J Lawitz, Brooke Army Medical Ctr, SanAntonio, TX; Mark A Jeffries, Wilford Hall USAF Medical Center, San Antonio, TX; Norma S Cantu, Shailesh C Kadakia, The Alamo Study Group, Brooke Army Medical Ctr, San Antonio, TX


Book ID
118689044
Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
196 KB
Volume
34
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.